Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: Total gastrectomy and proximal gastrectomy (PG) are both treatment options for proximal gastric cancer. Currently, there is no consensus on which procedure is better. The aim of this study was to compare the operative outcomes between proximal gastrectomy and total gastrectomy in the treatment of proximal gastric cancer.

Methods: Between January 2000 and Oct 2022, patients underwent either proximal gastrectomy with double tract reconstruction (PG-DTR) or total gastrectomy with Roux-en-Y reconstruction (TG-RY) for proximal gastric cancer were included. The clinicopathologic characteristics and operative outcomes were compared between the two groups. Propensity score matching was performed to compare the short- and long-term outcomes between the two groups.

Results: A total of 263 patients were included in the study. After propensity-score matching, there was no significant difference in clinicopathological characteristics between the two groups. The TG-RY group had more retrieved lymph nodes (37.8 ±18.6 vs. 28.7±15.4, p=0.022) and a longer hospital stay (13.6±10.2 vs. 9.4± 3.3 days, p=0.036) than the PG-DTR group. Surgical complications were similar between the two groups. The PG-DTR group had a greater prevalence of reflux esophagitis (21.4% vs. 7.1%, p=0.034), a higher postoperative/preoperative body weight ratio (0.91±0.08 vs. 0.84±0.14, p=0.021), and a higher postoperative/preoperative serum albumin ratio (1.07±0.11 vs. 0.96±0.18, p=0.004) than the TG-RY group.

Conclusion: Compared with TG-RY, PG-DTR was associated with better postoperative nutritional status and comparable operative complications.

Download full-text PDF

Source
http://dx.doi.org/10.1097/JCMA.0000000000001287DOI Listing

Publication Analysis

Top Keywords

total gastrectomy
16
proximal gastric
16
operative outcomes
12
gastric cancer
12
proximal gastrectomy
12
proximal
8
outcomes proximal
8
gastrectomy proximal
8
gastrectomy treatment
8
pg-dtr group
8

Similar Publications

Background: Bariatric surgery (BS) is the most effective treatment for severe obesity, but a significant proportion of patients experience insufficient weight loss (IWL) or weight regain. Glucagon-like peptide-1 receptor agonists (arGLP-1) have emerged as a promising adjunctive therapy for managing these suboptimal outcomes. This study evaluates the efficacy and safety of arGLP-1 in patients with IWL or WR after BS.

View Article and Find Full Text PDF

Background: Hypocalcemia is common after cervical procedures. Patients who have undergone Roux-en-Y gastric bypass (RYGB) experience increased risk for post-thyroidectomy hypocalcemia. This association has not been elucidated for nonbariatric operations that bypass the duodenum.

View Article and Find Full Text PDF

Gastrosplenic fistula is a rare complication, most often secondary to gastric or splenic lymphoma. Severe gastrosplenic fistula can cause life-threatening upper gastrointestinal bleeding, making early diagnosis and intervention critical for a favorable prognosis. Currently, surgical intervention remains the primary treatment; however, outcomes are often suboptimal.

View Article and Find Full Text PDF

Background: The development of cholelithiasis and its subsequent complications are a known risk after vertical sleeve gastrectomy (VSG) due to rapid weight loss. Although controversial, concomitant cholecystectomy (CCY) at the time of bariatric surgery has been proposed, with multiple studies investigating simultaneous CCY with Roux-en-Y gastric bypass. Despite VSG being the most commonly performed bariatric surgery in the United States (US) and globally, few studies have investigated the simultaneous VSG and CCY.

View Article and Find Full Text PDF